UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): APRIL 25, 2003
INTEGRA LIFESCIENCES HOLDINGS CORPORATION
(Exact name of Registrant as specified in its charter)
DELAWARE 0-26224 51-0317849
(State or other jurisdiction of (Commission File Number) (I.R.S. Employer
incorporation or organization) Identification No.)
311 ENTERPRISE DRIVE
PLAINSBORO, NJ 08536
(Address of principal executive offices) (Zip Code)
(609)-275-0500
(Registrant's telephone number, including area code)
NOT APPLICABLE
(Former name or former address, if changed since last report)
ITEM 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(a) Not applicable
(b) Not applicable
(c) Exhibits.
Exhibit
Number Description of Exhibit
------- ----------------------
99.1 Press release issued April 25, 2003 regarding earnings for the quarter
ended March 31, 2003
ITEM 9. Information Provided Under Item 12 (Results of Operations and Financial
Condition)
The information required by Item 12 is being provided under Item 9 pursuant to
Securities and Exchange Commission interim filing guidance provided in SEC press
release No. 2003-41.
The following information is furnished pursuant to Item 12, "Results of
Operations and Financial Condition." The information in this Form 8-K and the
Exhibit attached hereto shall not be deemed "filed" for purposes of Section 18
of the Securities Act of 1934, nor shall it be deemed incorporated by reference
in any filing under the Securities Act of 1933, except as shall be expressly set
forth by specific reference in such filing.
On April 25, 2003, Integra Life Sciences Corporation issued a press release
announcing financial results for the quarter ended March 31, 2003. A copy of the
press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized, as of the 25th day of April, 2003.
INTEGRA LIFESCIENCES HOLDINGS CORPORATION
BY: /s/ STUART M. ESSIG
-----------------------------
STUART M. ESSIG
PRESIDENT AND CHIEF EXECUTIVE OFFICER
Exhibit Index
-------------
Exhibit
Number Description of Exhibit
------- ----------------------
99.1 Press release issued April 25, 2003 regarding earnings for the quarter
ended March 31, 2003